Table 1 Association between circSMAD2 expression and clinicopathologic characteristics of GBC patients
From: Knockdown of circSMAD2 inhibits the tumorigenesis of gallbladder cancer through binding with eIF4A3
Characteristics | Cases | Low expression of circSMAD2 (%) | High expression of circSMAD2 (%) | χ2 value | P value |
|---|---|---|---|---|---|
Sex | Â | Â | Â | 0.833 | 0.3613 |
 Male | 8 | 5 (50%) | 3 (42.9%) |  |  |
 Female | 12 | 5 (50%) | 7 (57.1%) |  |  |
Age (Years) | Â | Â | Â | 0.800 | 0.3711 |
  < 60 | 10 | 6 (60%) | 4 (40%) |  |  |
  ≥ 60 | 10 | 4 (40%) | 6 (60%) |  |  |
TNM stage (AJCC) | Â | Â | Â | 1.978 | 0.1596 |
 0-II | 7 | 5 (50%) | 2 (20%) |  |  |
 III-IV | 13 | 5 (50%) | 8 (80%) |  |  |